During the past decade, Southeast Gynecologic Oncology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeast Gynecologic Oncology Associates" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Southeast Gynecologic Oncology Associates" are "Fallopian Tube Endometrioid Adenocarcinoma" (3 trials), "Fallopian Tube Mucinous Adenocarcinoma" (3 trials), "Fallopian Tube Transitional Cell Carcinoma" (3 trials), "Ovarian Endometrioid Adenocarcinoma" (3 trials) and "Ovarian Mucinous Adenocarcinoma" (3 trials). Many other conditions were trialed in "Southeast Gynecologic Oncology Associates" in a lesser frequency.

Most popular intervention types in "Southeast Gynecologic Oncology Associates" are "Drug" (5 trials), "Other" (4 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (5 trials), "Carboplatin" (4 trials), "Quality-of-Life Assessment" (4 trials), "Laboratory Biomarker Analysis" (3 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Southeast Gynecologic Oncology Associates" are 5 trials for "Female" genders.

Currently, there are NaN active trials in "Southeast Gynecologic Oncology Associates". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Southeast Gynecologic Oncology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southeast Gynecologic Oncology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".